These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7075570)

  • 1. Comparative bioavailability of phenytoin from generic formulations in the United Kingdom.
    Chen SS; Allen J; Oxley J; Richens A
    Epilepsia; 1982 Apr; 23(2):149-52. PubMed ID: 7075570
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioavailability and dissolution of proprietary and generic formulations of phenytoin.
    Soryal I; Richens A
    J Neurol Neurosurg Psychiatry; 1992 Aug; 55(8):688-91. PubMed ID: 1527539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the bioavailability of Polfa phenytoin tablets].
    Lazowski J; Lypka A; Zadrozyńska E; Pakszys W
    Neurol Neurochir Pol; 1978; 12(3):251-5. PubMed ID: 683430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dissolution rates and bioavailability of phenytoin preparations (author's transl)].
    Brandau R; Wehnert HU
    Arzneimittelforschung; 1979; 29(3):552-5. PubMed ID: 582744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the bioavailability of five different phenytoin preparations.
    Hirji MR; Measuria H; Kuhn S; Mucklow JC
    J Pharm Pharmacol; 1985 Aug; 37(8):570-2. PubMed ID: 2864420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable-isotope methodology for the bioavailability study of phenytoin during multiple-dosing regimens.
    Kasuya Y; Mamada K; Baba S; Matsukura M
    J Pharm Sci; 1985 May; 74(5):503-7. PubMed ID: 4020625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of formulation on dissolution and bioavailability of phenytoin tablets.
    Chakrabarti S; Belpaire F; Moerman E
    Pharmazie; 1980; 35(10):627-9. PubMed ID: 7454745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of simultaneously ingested milk on phenytoin bioavailability.
    Dotson R; Dickinson L; Kang H; Dasheiff R
    Neurology; 1985 Oct; 35(10):1526-7. PubMed ID: 3839911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid and slow release phenytoin in epileptic patients at steady state: assessment of relative bioavailability utilizing Michaelis-Menten parameters.
    Sawchuk RJ; Pepin SM; Leppik IE; Gumnit RJ
    J Pharmacokinet Biopharm; 1982 Aug; 10(4):383-91. PubMed ID: 7153871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter: Bioavailability of drugs after intramuscular injection.
    Cameron JD; Hedley DW
    Lancet; 1975 Mar; 1(7908):700. PubMed ID: 47135
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioavailability of phenytoin on single and multiple oral doses of two dosage forms in normal subjects.
    Kohda Y; Nishihara K; Isozaki S; Saitoh Y; Nakagawa F; Tamura Z
    J Pharmacobiodyn; 1983 Jan; 6(1):46-55. PubMed ID: 6854522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the bioavailability of two brands of phenytoin.
    Gibberd FB; Spencer KM; Webley M; Berry D
    Br J Clin Pharmacol; 1982 Mar; 13(3):455-6. PubMed ID: 7059449
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: Bioavailability of phenytoin.
    Tammisto P; Kauko K; Viukari M
    Lancet; 1976 Jan; 1(7953):254-5. PubMed ID: 55567
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of increased bioavailability of phenytoin tablets on serum phenytoin concentration in epileptic out-patients.
    Neuvonen PJ; Bardy A; Lehtovaara R
    Br J Clin Pharmacol; 1979 Jul; 8(1):37-41. PubMed ID: 552295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability and clinical usefulness of low-strength tablets of phenytoin.
    Mura P; Bramanti G; Liguori A; Polidori G; Santoni G; Landini A; Zaccara G; Muscas GC; Messori A
    Farmaco Prat; 1986 Oct; 41(10):313-25. PubMed ID: 3792533
    [No Abstract]   [Full Text] [Related]  

  • 16. Review of alterations in oral phenytoin bioavailability associated with formulation, antacids, and food.
    Cacek AT
    Ther Drug Monit; 1986; 8(2):166-71. PubMed ID: 3726929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of phenytoin: comparison between three preparations.
    Kitzes R; Ackerman Z; Levy M; Frumerman I; Shved A; Garty M
    Isr J Med Sci; 1985 Apr; 21(4):323-6. PubMed ID: 3997494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability and pharmacokinetics of phenytoin during pregnancy.
    Lander CM; Smith MT; Chalk JB; de Wytt C; Symoniw P; Livingstone I; Eadie MJ
    Eur J Clin Pharmacol; 1984; 27(1):105-10. PubMed ID: 6489420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of serum phenytoin levels in epileptic patients who swallowed their phenytoin tablets with or without previous chewing.
    Bielmann P; Levac T
    Eur J Clin Pharmacol; 1978 Nov; 14(3):191-4. PubMed ID: 729613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic failures in epileptic children due to impaired diphenylhydantoin bioavailability.
    Koren G; Brand N; Daney S; Halkin H
    Isr J Med Sci; 1982 Jun; 18(6):721-3. PubMed ID: 7107212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.